Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid in Elderly Intertrochanteric Femoral Fracture (Real-World Ambispective Cohort)
ChiCTR2600115980Phase 4Not yet recruiting
- Sponsor
- Zhongda Hospital, Southeast University
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tranexamic acid in intertrochanteric fracture (3 cohorts), sponsored by Zhongda Hospital, Southeast University. Primary endpoint: Blood transfusion rate. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
intertrochanteric fracture
Beyond the preview
Go deeper on ChiCTR2600115980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600115980.